Mr Samuel Joseph Aloi Iv, DPT | |
306 W Main St, Bridgeport, WV 26330-1751 | |
(304) 842-3137 | |
Not Available |
Full Name | Mr Samuel Joseph Aloi Iv |
---|---|
Gender | Male |
Speciality | Physical Medicine & Rehabilitation |
Location | 306 W Main St, Bridgeport, West Virginia |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659095115 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208100000X | Physical Medicine & Rehabilitation | 004535 (West Virginia) | Primary |
Entity Name | Bridgeport Physical Therapy Services, Inc. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912086158 PECOS PAC ID: 3678501855 Enrollment ID: O20050729000007 |
News Archive
Nearly a year since the world first learned of the novel coronavirus disease 2019, COVID-19, many questions remain about SARS-CoV-2, the virus behind this pandemic: Where did it come from, how did it spread so widely and rapidly, and how can we stop similar outbreaks in the future?
The Canadian Cancer Society and the Pediatric Oncology Group of Ontario (POGO) today announced that they have joined forces to improve the quality of outcomes for children and adolescents diagnosed with cancer and their families.
The Ebola virus travels from person to person through direct contact with infected body fluids. But how long can the virus survive on glass surfaces or countertops? How long can it live in wastewater when liquid wastes from a patient end up in the sewage system? In an article published Dec. 9 in the journal Environmental Science & Technology Letters, Kyle Bibby of the University of Pittsburgh reviews the latest research to find answers to these questions.
A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.
Researchers at Mayo Clinic Cancer Center have identified a novel gene that can contribute to a woman's susceptibility for developing ovarian cancer. Researchers identified the gene, called HNF1B, through large-scale analysis of more than 16,000 women with ovarian cancer and more than 26,000 healthy women.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Samuel Joseph Aloi Iv, DPT 306 W Main St, Bridgeport, WV 26330-1751 Ph: (304) 842-3137 | Mr Samuel Joseph Aloi Iv, DPT 306 W Main St, Bridgeport, WV 26330-1751 Ph: (304) 842-3137 |
News Archive
Nearly a year since the world first learned of the novel coronavirus disease 2019, COVID-19, many questions remain about SARS-CoV-2, the virus behind this pandemic: Where did it come from, how did it spread so widely and rapidly, and how can we stop similar outbreaks in the future?
The Canadian Cancer Society and the Pediatric Oncology Group of Ontario (POGO) today announced that they have joined forces to improve the quality of outcomes for children and adolescents diagnosed with cancer and their families.
The Ebola virus travels from person to person through direct contact with infected body fluids. But how long can the virus survive on glass surfaces or countertops? How long can it live in wastewater when liquid wastes from a patient end up in the sewage system? In an article published Dec. 9 in the journal Environmental Science & Technology Letters, Kyle Bibby of the University of Pittsburgh reviews the latest research to find answers to these questions.
A clinical study co-led by the Montreal Heart Institute and Innovaderm Research Inc., which was presented today at the annual meeting of the American Academy of Dermatology, shows that a new treatment for psoriasis could be associated with a significant decrease in vascular inflammation, a major risk factor of cardiovascular disease.
Researchers at Mayo Clinic Cancer Center have identified a novel gene that can contribute to a woman's susceptibility for developing ovarian cancer. Researchers identified the gene, called HNF1B, through large-scale analysis of more than 16,000 women with ovarian cancer and more than 26,000 healthy women.
› Verified 9 days ago
Dr. Kerri T. Johnson, DPT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 415 Benedum Dr, Bridgeport, WV 26330 Phone: 877-842-9887 |